Cargando…

Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia: A Systematic Review and Meta-analysis

IMPORTANCE: Questions of whether and how cortical thickness (CTh) alterations differ over the course of schizophrenia (SCZ) have yet to be resolved. OBJECTIVE: To characterize CTh alterations across illness stages in SCZ. DATA SOURCES: PubMed, Embase, Web of Science, and Science Direct were screened...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Youjin, Zhang, Qian, Shah, Chandan, Li, Qian, Sweeney, John A., Li, Fei, Gong, Qiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047772/
https://www.ncbi.nlm.nih.gov/pubmed/35476125
http://dx.doi.org/10.1001/jamapsychiatry.2022.0799
Descripción
Sumario:IMPORTANCE: Questions of whether and how cortical thickness (CTh) alterations differ over the course of schizophrenia (SCZ) have yet to be resolved. OBJECTIVE: To characterize CTh alterations across illness stages in SCZ. DATA SOURCES: PubMed, Embase, Web of Science, and Science Direct were screened for CTh studies published before June 15, 2021. STUDY SELECTION: Original studies comparing whole-brain CTh alterations from healthy controls in individuals at clinical high-risk (CHR), first episode of psychosis (FEP), and long-term illness stages of SCZ were included. DATA EXTRACTION AND SYNTHESIS: This preregistered systematic review and meta-analysis followed PRISMA reporting guidelines. Separate and pooled meta-analyses were performed using seed-based d mapping. Meta-regression analyses were conducted. MAIN OUTCOMES AND MEASURES: Cortical thickness differences from healthy control individuals across illness stages. RESULTS: Ten studies comprising 859 individuals with CHR (mean [SD] age, 21.02 [2.66] years; male, 573 [66.7%]), 12 studies including 671 individuals with FEP (mean [SD] age, 22.87 [3.99] years; male, 439 [65.4%]), and 10 studies comprising 579 individuals with long-term SCZ (mean [SD] age, 41.58 [6.95] years; male, 396 [68.4%]) were included. Compared with healthy control individuals, individuals with CHR showed cortical thinning in bilateral medial prefrontal cortex (z = −1.01; P < .001). Individuals with FEP showed cortical thinning in right lateral superior temporal cortex (z = −1.34; P < .001), right anterior cingulate cortex (z = −1.44; P < .001), and right insula (z = −1.14; P = .002). Individuals with long-term SCZ demonstrated CTh reductions in right insula (z = −3.25; P < .001), right inferior frontal cortex (z = −2.19; P < .001), and left (z = −2.37; P < .001) and right (z = −1.94; P = .002) temporal pole. There were no significant CTh differences between CHR and FEP. Individuals with long-term SCZ showed greater cortical thinning in right insula (z = −2.58; P < .001), right inferior frontal cortex (z = −2.32; P < .001), left lateral temporal cortex (z = −1.91; P = .002), and right temporal pole (z = −1.82; P = .002) than individuals with FEP. Combining all studies on SCZ, accelerated age-related CTh reductions were found in bilateral lateral middle temporal cortex and right pars orbitalis in inferior frontal cortex. CONCLUSIONS AND RELEVANCE: The absence of significant differences between FEP and CHR noted in this systematic review and meta-analysis suggests that the onset of psychosis was not associated with robust CTh reduction. The greater cortical thinning in long-term SCZ compared with FEP with accelerated age-related reduction in CTh suggests progressive neuroanatomic alterations following illness onset. Caution in interpretation is needed because heterogeneity in samples and antipsychotic treatment may confound these results.